Loading
Latest filing published 15 Dec 2023 for NEPHROS INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alisa Lask, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Nephros Inc and RVL Pharmaceuticals plc. Over a trading history stretching from 14 December 2021 to 13 December 2023, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 15 December 2023, reports a share grant in Nephros Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations